PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Cerulean Associates, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

John Avellanet to Speak at International Contract Pharma Conference on Supplier Management - John Avellanet, Managing Director of Cerulean Associates, will be helping kick off the 2nd day of the international 7th Annual Contract Pharma Contracting and Outsourcing Conference, to be held in New Brunswick, New Jersey on Friday, September 26th
John Avellanet to Speak at International Contract Pharma Conference on Supplier Management

 

NewswireToday - /newswire/ - Williamsburg, VA, United States, 2008/09/02 - John Avellanet, Managing Director of Cerulean Associates, will be helping kick off the 2nd day of the international 7th Annual Contract Pharma Contracting and Outsourcing Conference, to be held in New Brunswick, New Jersey on Friday, September 26th.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Williamsburg-based John Avellanet, Managing Director of Cerulean Associates, will be helping kick off the 2nd day of the international 7th Annual Contract Pharma Contracting and Outsourcing Conference, to be held in New Brunswick, New Jersey on Friday, September 26th.

The Conference covers supplier topics critical to pharmaceutical, biotechnology and medical device executives, and includes top speakers from the US Food and Drug Administration (FDA) and industry. Topics include risk-based supplier management programs, FDA inspection issues, global outsourcing trends, and best practices for handling global supply chains. More information about the conference can be found on the web at: contractpharma.com/2008conference.

Mr. Avellanet will be discussing best practices for designing a risk-based supplier selection and vendor qualification program based on his own experiences and those of his clients.

Later this month, Mr. Avellanet will be speaking to the Management Roundtable on how to prevent contractors and outsourced partners stealing trade secrets (September 10), providing an update on the FDA’s revised Part 11 and EU’s Annex 11 as the guest of an FDA Expert Briefing (September 18), and speaking to the Virginia Commonwealth University business school on the role of IT in regulatory compliance (September 20).

John Avellanet is an internationally recognized expert, speaker and syndicated author on cost-effective compliance and quality systems, including computer and records management compliance. A former C-level executive for a Fortune 50 combination device and biotechnology subsidiary, he writes and publishes the monthly executive newsletter, SmarterCompliance™. In 2006, he founded his independent consulting firm, Cerulean Associates, LLC.

Cerulean Associates, LLC (ceruleanllc.com) is a small, private compliance consulting company that helps clients achieve cost-effective lean compliance, quality by design, faster time to market and prevent trade secret theft.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Cerulean Associates, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


John Avellanet to Speak at International Contract Pharma Conference on Supplier Management

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: John Avellanet - CeruleanLLC.com 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cerulean Associates, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Cerulean Associates, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Al Rowaad Advocates & Legal Consultants

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)